+
Site Tour

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

PFO closure with Amplatzer™ Talisman™ PFO Occluder: First large-scale comparative study between closure vs. non-closure in patients >60 years with presumed PFO-associated stroke.

Download

Related Resources

Clinical trial summary: Piccolo™

Clinical insights: Amulet™

Amplatzer™ Trevisio™ case report by Prof. Berger

Data Summary PFO closure in patients > 60 Years

Amplatzer™ Septal Occluder (ASO) brochure

Talisman™ vs Occlutech‡ Clinical Insights

Monitoring for AF prior to PFO closure

Clinical insights: PFO stroke

TRENDING TOPICS

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 25, presented by G. Singh

Poster: Primary MR in the Very Elderly

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

CONNEXT


TV
RELATED RESOURCES

LAAO Summit 2022: Panel discussion – Session 1

AV Valves Summit 2024 | Closing of Day 2

LAAO Summit 2023: The clinical reality

TAVI Summit - Cardiac imaging and morphology

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit 2023: Live Case: Salamanca

Case Transmission | Tricuspid focus

LAAO Summit 2023: LAAO therapies

PremiClose 2024: The PDA, when to intervene

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline